These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24303843)

  • 1. Brugada phenocopy with a flecainide overdose: a pharmacological dose effect?
    Chubb H; Cooklin M; Rosenthal E
    J Cardiovasc Electrophysiol; 2014 May; 25(5):547-548. PubMed ID: 24303843
    [No Abstract]   [Full Text] [Related]  

  • 2. About Brugada phenocopy: Brugada phenocopy with a flecainide overdose: a pharmacological dose effect?
    Anselm DD; Baranchuk A
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):E2. PubMed ID: 24451029
    [No Abstract]   [Full Text] [Related]  

  • 3. "About Brugada phenocopy": Brugada phenocopy with a flecainide overdose: a pharmacological dose effect?
    Chubb H; Cooklin M; Rosenthal E
    J Cardiovasc Electrophysiol; 2014 Mar; 25(3):E1. PubMed ID: 24451005
    [No Abstract]   [Full Text] [Related]  

  • 4. Wide Complex Tachycardia in a Patient With a History of Atrial Fibrillation.
    Hegde S; Kumar V
    JAMA Intern Med; 2016 Mar; 176(3):386-8. PubMed ID: 26784121
    [No Abstract]   [Full Text] [Related]  

  • 5. Long-term flecainide therapy in type 3 long QT syndrome.
    Chorin E; Taub R; Medina A; Flint N; Viskin S; Benhorin J
    Europace; 2018 Feb; 20(2):370-376. PubMed ID: 28339995
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a Brugada pattern ECG precipitated by excessive-dose flecainide provide a diagnosis of a Brugada syndrome patient and/or contraindicate its use? A case study.
    Reiffel JA
    Circ Arrhythm Electrophysiol; 2011 Aug; 4(4):e47-51. PubMed ID: 21846883
    [No Abstract]   [Full Text] [Related]  

  • 7. Brugada-type ECG pattern in patients treated with oral flecainide for lone atrial fibrillation: is there any clinical implication?
    Letsas KP; Weber R; Arentz T; Kalusche D
    Hellenic J Cardiol; 2009; 50(4):338-9. PubMed ID: 19622506
    [No Abstract]   [Full Text] [Related]  

  • 8. Permanent atrioventricular block after flecainide testing.
    Luna-López R; Datino T; Espinosa MÁ; Fernández-Avilés F; Arenal Á
    Rev Esp Cardiol (Engl Ed); 2020 Feb; 73(2):177-178. PubMed ID: 31631050
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of untreatable ventricular arrhythmias during pharmacologic challenges with sodium channel blockers for suspected Brugada syndrome.
    Poli S; Toniolo M; Maiani M; Zanuttini D; Rebellato L; Vendramin I; Dametto E; Bernardi G; Bassi F; Napolitano C; Livi U; Proclemer A
    Europace; 2018 Feb; 20(2):234-242. PubMed ID: 28521022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ECG diagnosis: flecainide toxicity.
    Levis JT
    Perm J; 2012; 16(4):53. PubMed ID: 23251119
    [No Abstract]   [Full Text] [Related]  

  • 11. Is flecainide dangerous in long QT-3 patients?
    Beinart R; Michailidis A; Gurevitz OT; Glikson M
    Pacing Clin Electrophysiol; 2009 Jan; 32(1):143-5. PubMed ID: 19140927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies in Brugada syndrome.
    Cerrone M
    Trends Cardiovasc Med; 2018 May; 28(4):284-292. PubMed ID: 29254832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loperamide Mimicking Brugada Pattern.
    Rojas SF; Oglat A; Bonilla HMG; Jeroudi O; Sharp W; Valderrábano M; Schurmann PA
    Methodist Debakey Cardiovasc J; 2018; 14(4):e1-e3. PubMed ID: 30788023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Late positive flecainide challenge test for Brugada syndrome.
    Gray B; McGuire M; Semsarian C; Medi C
    Heart Rhythm; 2014 May; 11(5):898-900. PubMed ID: 24582606
    [No Abstract]   [Full Text] [Related]  

  • 15. Delayed positive response to a flecainide test in a patient with suspected Brugada syndrome: a worrisome finding.
    de-Riva-Silva M; Montero-Cabezas JM; Fontenla-Cerezuela A; Salguero-Bodes R; López-Gil M; Arribas-Ynsaurriaga F
    Rev Esp Cardiol (Engl Ed); 2014 Aug; 67(8):674-5. PubMed ID: 25037552
    [No Abstract]   [Full Text] [Related]  

  • 16. Flecainide overdose causing a Brugada-type pattern on electrocardiogram in a previously well patient.
    Soni S; Gandhi S
    Am J Emerg Med; 2009 Mar; 27(3):375.e1-375.e3. PubMed ID: 19328402
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological Provocation of Outflow-Tract Tachycardia in a Patient With Brugada Syndrome.
    Bürkle G; Schäfer H; Marschall C; Brugada P; Ehrlich JR
    Can J Cardiol; 2016 Dec; 32(12):1577.e5-1577.e7. PubMed ID: 27032887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.
    Padfield GJ; AlAhmari L; Lieve KV; AlAhmari T; Roston TM; Wilde AA; Krahn AD; Sanatani S
    Heart Rhythm; 2016 Feb; 13(2):609-13. PubMed ID: 26416620
    [No Abstract]   [Full Text] [Related]  

  • 19. [Brugada syndrome unmasked by oral flecainide in a patient with a history of supraventricular tachycardia].
    Díaz-Muñoz J; García-Niebla J
    Semergen; 2015; 41(1):54-6. PubMed ID: 24703583
    [No Abstract]   [Full Text] [Related]  

  • 20. Role of syncope in predicting adverse outcomes in patients with suspected Brugada syndrome undergoing standardized flecainide testing.
    Pablo Flórez J; García D; Valverde I; Rubín J; Pérez D; González-Vasserot M; Reguero J; María de la Hera J; Avanzas P; Gómez J; Coto E; Morís C; Calvo D
    Europace; 2018 Jun; 20(FI1):f64-f71. PubMed ID: 29309564
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.